Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies

Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies

Objective: Insulin antibody (IA)-mediated insulin resistance (IR) is a rare condition for which immunosuppressive regimens have been described. However, these raise the risk of infection, and the drugs may not be effectively metabolized in patients with liver disease. A 61-year old male with type 2...

Full description

Bibliographic Details
Main Authors: Danielle Brooks, MD, Priya Grewal, MD, Ian Baine, MD, PhD, Suzanne A. Arinsburg, DO, Samir Maximos, MD, Nirali A. Shah, MD
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:AACE Clinical Case Reports
Subjects:
insulin antibodies
insulin resistance
mycophenolate mofetil
plasmapheresis
type 2 diabetes
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060521000444

Similar Items

Similar Items